AYM.F : Summary for ALBANY MOLECULAR DL-,01 - Yahoo Finance

U.S. Markets close in 4 hrs 16 mins

Albany Molecular Research, Inc. (AYM.F)


Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
15.620.00 (0.00%)
As of 9:34 AM EST. Market open.
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Previous Close15.62
Open15.62
Bid16.25 x 26300
Ask16.57 x 25300
Day's Range15.62 - 15.62
52 Week Range11.71 - 16.22
Volume760
Avg. Volume13
Market Cap558.35M
BetaN/A
PE Ratio (TTM)-10.69
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Is Albany Molecular Research, Inc. (AMRI) A Good Stock To Buy?
    Insider Monkey3 days ago

    Is Albany Molecular Research, Inc. (AMRI) A Good Stock To Buy?

    Looking for high-potential stocks? Just follow the big players within the hedge fund industry. Why should you do so? Let’s take a brief look at what statistics have to say about hedge funds’ stock picking abilities to illustrate. The Standard and Poor’s 500 Index returned approximately 7.6% in the 12 months ending November 21, with […]

  • PR Newswire9 days ago

    AMRI Announces API Supply Agreement with Shire

    ALBANY, N.Y., Nov. 29, 2016 /PRNewswire/ -- AMRI (AMRI) announced today that it has entered into a multi-year supply agreement for an undisclosed product with Shire US Manufacturing, Inc. which product has been in AMRI's portfolio through the required stages of development.  Shire plc, is a leading global biotechnology company focused on developing and marketing innovative medicines for patients with rare diseases and other highly specialized conditions. The terms of the agreement are confidential.  This is the second such multi-year agreement between AMRI and Shire, as AMRI has also been supplying a key neuroscience product to Shire. "This agreement builds on the long-standing development and manufacturing relationship between Shire and AMRI," said William S. Marth, President and CEO of AMRI.

  • PR Newswire24 days ago

    AMRI to Present Two Posters at AAPS 2016

    ALBANY, N.Y., Nov. 14, 2016 /PRNewswire/ -- AMRI (NASDAQ: AMRI), a premier contract services provider to the life sciences industry, will be presenting two posters at the 2016 AAPS Annual Meeting and Exposition, ...